Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data
ConclusionOur results demonstrate that various currently FDA-approved drugs might be candidates for targeted therapy of GC. For clinical trials, cancer patients should be selected based on the genomic profile of their tumor.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Databases & Libraries | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Herceptin | Study